ADIL - adialpharma.com Sales Growth YoY (TTM)

Graphic logo of adialpharma.com (ADIL)

Adial Pharmaceuticals independently conducts final confirmatory tests of its developments, collaborating only with research centers. Future revenue is based on the market launch of an innovative alcoholism treatment for individuals with specific genetics. Risks are associated with a potential increase in logistics costs due to geopolitics. The year-over-year commercial revenue dynamics for the rolling year demonstrate revenue trends, where the 0.00 level reflects the current magnitude.

ADIL (Adial Pharmaceuticals) Revenue Growth YoY (Last 12 Months) history from 02/11/2024 to 10/29/2026

Adial Pharmaceuticals (ADIL) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Summary company analytics:ADIL (Adial Pharmaceuticals, Inc.)
Finished products of Adial

This indicator measures revenue dynamics over a rolling twelve-month period, allowing for a real-time assessment of trading momentum and the elimination of seasonal distortions when analyzing business scaling. The year-over-year sales volume growth trajectory for TTM on the GURU.Markets platform demonstrates the ability of Adial Pharmaceuticals (ADIL) to monetize its patents amidst strict FDA regulatory oversight and high barriers to entry in the addiction treatment niche.